Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CAP-100 / Catapult Therap
NCT04704323: CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia	Recruiting	1	18	Europe, US	CAP-100	Catapult Therapeutics	Lymphocytic Leukemia, Chronic, SLL	01/25	04/25